Cypress Systems

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Cypress Systems, Inc. is a biotech company headquartered in Madera, California and is best known for its research, in collaboration with the National Cancer Institute (NCI), regarding the use of selenium supplementation for the prevention of a variety of cancers.[1] Cypress Systems, Inc. also manufactures selenium, zinc, and chromium for the nutraceutical industry.

In 1983, the now-deceased Dr. Larry C. Clark conducted a Nutritional Prevention of Cancer (NPC) study. This historic trial illustrated that selenium supplementation prevented a variety of cancers.[1] Since the trial of Dr. Larry Clark, numerous studies have found similar results of selenium being an effective agent in the prevention of a variety of cancers. (See a review of the studies in Selenium#Cancer).

Cypress focuses on the prevention of cancer through selenium supplementation, and addresses related health problems through a comprehensive health stewardship program. Much research is also being conducted in the area of selenium as an intervention agent in the prevention of AIDS and heart disease.

High profile executive[edit]

The COO of Cypress is Mark Whitacre, who is the highest level executive of a Fortune 500 company in US history to turn whistleblower. He was convicted and spent 812 years in federal prison for embezzling $9.5 million. This was discovered while he was acting as an FBI informant against ADM for international price fixing schemes. Cypress' management, along with several FBI agents involved with Whitacre's case, are lobbying for a presidential pardon for Whitacre,[2] and the head of the FBI's investigation into ADM went public calling Whitacre a national hero.

Coverage in the news media[edit]

References[edit]

External links[edit]